Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd (TORNTPHARM) last traded at ₹4,874, a market capitalisation of ₹1,85,372 crore, on a P/E of 83.1. Over the past 52 weeks the stock has ranged between ₹3,480 and ₹5,250. Torrent Pharmaceuticals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹4,921 crore and net profit of ₹566 crore. The next scheduled event is an other on 8 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Torrent Pharmaceuticals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Torrent Pharmaceuticals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹4,921 cr, up 54.8% from ₹3,178 cr a year earlier. Net profit was ₹566 cr, up 3.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,889 | 2,809 | 2,959 | 3,178 | 3,302 | 3,303 | 4,197 | 4,921 |
| Expenses | 1,950 | 1,895 | 1,995 | 2,146 | 2,219 | 2,215 | 2,841 | 3,257 |
| Operating profit | 939 | 914 | 964 | 1,032 | 1,083 | 1,088 | 1,356 | 1,664 |
| OPM % | 32% | 33% | 33% | 32% | 33% | 33% | 32% | 34% |
| Other income | -16 | 33 | -42 | -37 | -40 | -23 | -83 | -33 |
| Interest | 64 | 57 | 56 | 56 | 48 | 45 | 236 | 305 |
| Depreciation | 198 | 199 | 201 | 201 | 204 | 206 | 508 | 593 |
| Profit before tax | 661 | 691 | 665 | 738 | 791 | 814 | 529 | 733 |
| Tax % | 31% | 27% | 25% | 26% | 25% | 22% | 31% | 23% |
| Net profit | 453 | 503 | 498 | 548 | 591 | 635 | 364 | 566 |
| EPS (₹) | 13.38 | 14.86 | 14.71 | 16.19 | 17.46 | 18.76 | 10.76 | 16.72 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Torrent Pharmaceuticals Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 8,005 | 8,508 | 9,620 | 10,728 | 11,516 | 13,980 | 15,723 |
| Operating profit | 2,480 | 2,431 | 2,842 | 3,368 | 3,721 | 4,558 | 5,191 |
| OPM % | 31% | 29% | 30% | 31% | 32% | 33% | 33% |
| Net profit | 1,252 | 777 | 1,245 | 1,656 | 1,911 | 2,138 | 2,156 |
| EPS (₹) | 36.99 | 22.97 | 36.79 | 48.94 | 56.47 | 63.92 | 63.70 |
TTM is the trailing twelve months to the most recent quarter.
Torrent Pharmaceuticals Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- 12%
- 3 Years
- 13%
- TTM
- 33%
- 10 Years
- 2%
- 5 Years
- 12%
- 3 Years
- 22%
- TTM
- 10%
- 10 Years
- 20%
- 5 Years
- 26%
- 3 Years
- 36%
- 1 Year
- 33%
- 10 Years
- 22%
- 5 Years
- 24%
- 3 Years
- 26%
- Last Year
- 27%
Torrent Pharmaceuticals Ltd shareholding pattern
Promoters held 60.78% at Jul 2026, down from 68.31% at Sep 2025. FIIs 17.97% and DIIs 12.77%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 68.31% | 68.31% | 68.31% | 68.31% | 68.31% | 68.31% | 68.31% | 60.78% |
| FIIs | 16.17% | 16.31% | 16.09% | 15.92% | 16.13% | 16.18% | 15.44% | 17.97% |
| DIIs | 8.25% | 8.25% | 8.54% | 9.17% | 9.05% | 8.96% | 9.73% | 12.77% |
| Government | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.00% | 0.10% | 0.09% |
| Public | 7.17% | 7.02% | 6.93% | 6.47% | 6.41% | 6.55% | 6.42% | 8.39% |
| No. of shareholders | 85,035 | 86,005 | 81,856 | 78,226 | 76,214 | 83,811 | 85,776 | 1,40,599 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Torrent Pharmaceuticals Ltd events
The next scheduled event is an other on 8 Sept 2026.
- OtherPostal ballot for appointment of Shanti Ekambaram as Independent Director
- AGMPostal ballot for shareholder approval of resolutions
See the full results calendar for every Indian company reporting in the next 30 days.
Torrent Pharmaceuticals Ltd corporate filings
- Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Company Updatelow impact
Cruxal's analysis: Torrent Pharmaceuticals has issued an intimation regarding a scheduled investor meeting…
Read the full analysis - ESG RatingCompany Updatelow impact
Cruxal's analysis: Torrent Pharmaceuticals has provided an intimation under Regulation 30 of SEBI (LODR)…
Read the full analysis - Newspaper Advertisement for completion of dispatch of Postal Ballot NoticeCompany Updatelow impact
Cruxal's analysis: Torrent Pharmaceuticals has completed the dispatch of the Postal Ballot Notice to its…
Read the full analysis - Notice of Postal BallotAGM/EGMlow impact
Cruxal's analysis: Torrent Pharmaceuticals has issued a notice of postal ballot to seek shareholder approval…
Read the full analysis - Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2026Company Updatelow impact
Cruxal's analysis: Torrent Pharmaceuticals Limited has announced the availability of the transcript for its…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Torrent Pharmaceuticals Ltd
Cruxal reads every Torrent Pharmaceuticals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.